|
a |
|
b/README_eLife_Liu.txt |
|
|
1 |
This DATSETNAMEreadme.txt file was generated on 2022-05-18 by Li Liu |
|
|
2 |
|
|
|
3 |
GENERAL INFORMATION |
|
|
4 |
|
|
|
5 |
1. Title of Dataset: Datasets used in the manuscript "Early detection of cerebrovascular pathology and protective antiviral immunity by MRI" |
|
|
6 |
|
|
|
7 |
2. Author Information |
|
|
8 |
A. Principal Investigator Contact Information |
|
|
9 |
Name: Li Liu |
|
|
10 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
11 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
12 |
Email: li.liu3@nih.gov |
|
|
13 |
|
|
|
14 |
Name: Alan P. Koretsky |
|
|
15 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
16 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
17 |
Email: koretskya@ninds.nih.gov |
|
|
18 |
|
|
|
19 |
B. Associate or Co-investigator Contact Information |
|
|
20 |
Name: Stephen Dodd |
|
|
21 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
22 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
23 |
Email: doddst@ninds.nih.gov |
|
|
24 |
|
|
|
25 |
Name: Ryan D. Hunt |
|
|
26 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
27 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
28 |
Email: Ryan.Hunt@uvm.edu |
|
|
29 |
|
|
|
30 |
Name: Nikorn Pothayee |
|
|
31 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
32 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
33 |
Email: nikorn.pothayee@nih.gov |
|
|
34 |
|
|
|
35 |
Name: Tatjana Atanasijevic |
|
|
36 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
37 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
38 |
Email: tatjana.atanasijevic@nih.gov |
|
|
39 |
|
|
|
40 |
Name: Nadia Bouraoud |
|
|
41 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
42 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
43 |
Email: Nadia.Bouraoud@nih.gov |
|
|
44 |
|
|
|
45 |
Name: Dragan Maric |
|
|
46 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
47 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
48 |
Email: maricd@ninds.nih.gov |
|
|
49 |
|
|
|
50 |
Name: E. Ashley Moseman |
|
|
51 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
52 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
53 |
Email: ashley.moseman@duke.edu |
|
|
54 |
|
|
|
55 |
Name: Selamawit Gossa |
|
|
56 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
57 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
58 |
Email: selamawit.gossa@nih.gov |
|
|
59 |
|
|
|
60 |
Name: Dorian B. McGavern |
|
|
61 |
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health |
|
|
62 |
Address: 10 Center Drive, Building 10, Bethesda, MD 20892, USA |
|
|
63 |
Email: mcgavernd@ninds.nih.gov |
|
|
64 |
|
|
|
65 |
C. Alternate Contact Information |
|
|
66 |
Name: E. Ashley Moseman |
|
|
67 |
Institution: Duke University School of Medicine |
|
|
68 |
Address: Durham, NC 27710, USA |
|
|
69 |
Email: ashley.moseman@duke.edu |
|
|
70 |
|
|
|
71 |
3. Date of data collection: From 2017-12-01 to 2022-03-02 |
|
|
72 |
|
|
|
73 |
4. Geographic location of data collection: Bethesda, MD, USA |
|
|
74 |
|
|
|
75 |
5. Information about funding sources that supported the collection of the data: |
|
|
76 |
The Intramural Program of the National Institute of Neurological Disorders and Stroke (1ZIANS003047-15) for Alan P Koretsky |
|
|
77 |
The Intramural Program of the National Institute of Neurological Disorders and Stroke (1ZIANS003112-13) for Dorian B McGavern |
|
|
78 |
|
|
|
79 |
DATA & FILE OVERVIEW |
|
|
80 |
File List: |
|
|
81 |
Method of Data Collection.docx - Description of experimental methodology that used in this study. |
|
|
82 |
Source Data Fig 1.xlsx - Quantification of volume of hypointensity in the turbinates and numbers of hypointensity spots in the OB on day 4, 6, and 11. |
|
|
83 |
Source Data Fig 2.xlsx - Quantification of numbers of hypointensity spots in the brain (not including OB) on day 4, 6, and 11. |
|
|
84 |
Source Data Fig 3.xlsx - Quantification of IHC staining showed increased expression of endothelial VCAM-1 and ICAM-1 in the OB on day 6 of infection. Quantification of the volume of bleeding in the turbinates and the numbers of hypointensity spots in the OB and brain on day 6, in the isotype control group and anti-LFA-1/VLA-4 antibodies treated group. |
|
|
85 |
Source Data Fig 5.xlsx - Quantification of volume of bleeding in the turbinates and numbers of hypointensity spots in the OB and brain without or with T cells early and late transfer |
|
|
86 |
Source Data Fig 6.xlsx - Quantification of IHC study verified that antiviral CD8 T cells reduced VSV-induced brain bleeding. |
|
|
87 |
Source Data Fig 8.xlsx - Quantification of IHC study showing the activation of vessel endothelium cells and microglia were found at the ONL/GL and MCL/GCL on day 1. |
|
|
88 |
Source Data Figure 3-figure supplement 1.xlsx - Quantification of IHC staining showed increased expression of endothelial VCAM-1 and ICAM-1 in the OB and thalamus on day 6 of infection. |
|
|
89 |
Source Data Figure 6-figure supplement 1.xlsx - Quantification of bleeding volume in turbinates, and number of hypointensity spots in OB and brain without or with T cell transfer (5 x 105 T cells, and 3 x 106 T cells) on day 11. |
|
|
90 |
Source Data Figure 8-figure supplement 2.xlsx - Quantification of the number of hypointensity spots in OB and brain on day 6 and 11, upon transfer of unlabeled CD8 T cells or MPIO-labeled CD8 T cells. |
|
|
91 |
|
|
|
92 |
METHODOLOGICAL INFORMATION |
|
|
93 |
Method of Data Collection.docx |
|
|
94 |
|